Hosted on MSN

FDA moves to restrict compounding GLP-1 ingredients

The Food and Drug Administration said Friday it intends to restrict access to GLP-1 drug ingredients used in nonapproved compounded weight-loss products and that Hims & Hers Health Inc. could face ...
Yahoo

FDA moves to limit ingredients for bulk drug compounding

U.S. Food and Drug Commissioner Scott Gottlieb attends an interview at Reuters headquarters in New York City, U.S., October 10, 2017. REUTERS/Eduardo Munoz By Nate Raymond BOSTON (Reuters) - The U.S.